Header Logo

Connection

Allan Walkey to Hydrocortisone

This is a "connection" page, showing publications Allan Walkey has written about Hydrocortisone.
Connection Strength

1.925
  1. Bosch NA, Law AC, Walkey AJ. Immortal Time Bias Possibly Affecting Fludrocortisone-Hydrocortisone Findings-Reply. JAMA Intern Med. 2023 10 01; 183(10):1178-1179.
    View in: PubMed
    Score: 0.776
  2. Bosch NA, Teja B, Law AC, Pang B, Jafarzadeh SR, Walkey AJ. Comparative Effectiveness of Fludrocortisone and Hydrocortisone vs Hydrocortisone Alone Among Patients With Septic Shock. JAMA Intern Med. 2023 05 01; 183(5):451-459.
    View in: PubMed
    Score: 0.754
  3. Teja B, Berube M, Pereira TV, Law AC, Schanock C, Pang B, Wunsch H, Walkey AJ, Bosch NA. Effectiveness of Fludrocortisone Plus Hydrocortisone versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Am J Respir Crit Care Med. 2024 05 15; 209(10):1219-1228.
    View in: PubMed
    Score: 0.202
  4. Vail EA, Wunsch H, Pinto R, Bosch NA, Walkey AJ, Lindenauer PK, Gershengorn HB. Use of Hydrocortisone, Ascorbic Acid, and Thiamine in Adults with Septic Shock. Am J Respir Crit Care Med. 2020 12 01; 202(11):1531-1539.
    View in: PubMed
    Score: 0.159
  5. Law AC, Sahetya S, Walkey AJ, Delaney A. Low-dose corticosteroids and septic shock resolution: implications for randomized trial design? Intensive Care Med. 2018 08; 44(8):1366-1367.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.